BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8752577)

  • 1. A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat.
    McLean HA; Champagnat J; Denavit-Saubie M
    Eur J Neurosci; 1996 Jun; 8(6):1078-84. PubMed ID: 8752577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites.
    Branchereau P; Champagnat J; Roques BP; Denavit-Saubie M
    Neuroreport; 1992 Oct; 3(10):909-12. PubMed ID: 1330059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-GABA interactions in rat striatum.
    Rakovska A
    Neuropeptides; 1995 Nov; 29(5):257-62. PubMed ID: 8587661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA; Griffin EP; Shankley NP; Black JW
    Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution by GABA or glycine to Cl(-)-mediated synaptic transmission on rat hypoglossal motoneurons in vitro.
    Donato R; Nistri A
    J Neurophysiol; 2000 Dec; 84(6):2715-24. PubMed ID: 11110802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
    Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
    J Neurosci; 1997 Mar; 17(5):1838-47. PubMed ID: 9030642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro.
    Saleh TM; Kombian SB; Zidichouski JA; Pittman QJ
    Neuroscience; 1997 Mar; 77(1):23-35. PubMed ID: 9044371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic inhibition in the isolated respiratory network of neonatal rats.
    Brockhaus J; Ballanyi K
    Eur J Neurosci; 1998 Dec; 10(12):3823-39. PubMed ID: 9875360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study.
    Ferraro L; O'Connor WT; Glennon J; Tomasini MC; Bebe BW; Tanganelli S; Antonelli T
    Life Sci; 2000 Dec; 68(5):483-96. PubMed ID: 11197746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D; Smith GP
    Physiol Behav; 1998 Aug; 65(1):11-4. PubMed ID: 9811359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
    Léna I; Roques BP; Durieux C
    J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
    Xu XJ; Elfvin A; Hao JX; Fournié-Zaluski MC; Roques BP; Wiesenfeld-Hallin Z
    Neuropeptides; 1997 Jun; 31(3):287-91. PubMed ID: 9243527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
    Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
    Wu T; Wang HL
    Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of GABAergic synaptic transmission in the rostral nucleus of the solitary tract.
    Grabauskas G; Bradley RM
    Neuroscience; 1999; 94(4):1173-82. PubMed ID: 10625056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists.
    Hughes J; Hunter JC; Woodruff GN
    Neuropeptides; 1991 Jul; 19 Suppl():85-9. PubMed ID: 1679213
    [No Abstract]   [Full Text] [Related]  

  • 18. Respiratory rhythm generation and synaptic inhibition of expiratory neurons in pre-Bötzinger complex: differential roles of glycinergic and GABAergic neural transmission.
    Shao XM; Feldman JL
    J Neurophysiol; 1997 Apr; 77(4):1853-60. PubMed ID: 9114241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
    Singh L; Field MJ; Vass CA; Hughes J; Woodruff GN
    Br J Pharmacol; 1992 Jan; 105(1):8-10. PubMed ID: 1350747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas.
    Pérez de la Mora M; Hernandez-Gómez AM; Méndez-Franco J; Fuxe K
    Eur J Pharmacol; 1993 Dec; 250(3):423-30. PubMed ID: 8112402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.